References
- Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97(2):534–540. table of contents. doi:10.1213/01.ane.0000068822.10113.9e12873949
- Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17(2):131–157. doi:10.1016/j.jpain.2015.12.00826827847
- Argoff CE. Recent management advances in acute postoperative pain. Pain Pract. 2014;14(5):477–487. doi:10.1111/papr.1210823945010
- Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191–196. doi:10.1055/s-0033-135113824436674
- Oxlund J, Clausen AH, Veno S, et al. A randomized trial of automated intermittent ropivacaine administration vs. continuous infusion in an interscalene catheter. Acta Anaesthesiol Scand. 2018;62(1):85–93. doi:10.1111/aas.1301129034961
- Ng FY, Ng JK, Chiu KY, Yan CH, Chan CW. Multimodal periarticular injection vs continuous femoral nerve block after total knee arthroplasty: a prospective, crossover, randomized clinical trial. J Arthroplasty. 2012;27(6):1234–1238. doi:10.1016/j.arth.2011.12.02122325963
- Brown SL, Morrison AE. Local anesthetic infusion pump systems adverse events reported to the Food and Drug Administration. Anesthesiology. 2004;100(5):1305–1307. doi:10.1097/00000542-200405000-0003615114230
- Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T. Dexmedetomidine enhances the local anesthetic action of lidocaine via an alpha-2A adrenoceptor. Anesth Analg. 2008;107(1):96–101. doi:10.1213/ane.0b013e318176be7318635472
- Bulbring E, Wajda I. Biological comparison of local anaesthetics. J Pharmacol Exp Ther. 1945;85:78–84.21004444
- Mary LA, Giknis CBC. Clinical Laboratory Parameters for Crl: CD(SD)rats. Charles River Laboratories; 2006.
- Capogna G, Celleno D, Fusco P, Lyons G, Columb M. Relative potencies of bupivacaine and ropivacaine for analgesia in labour. Br J Anaesth. 1999;82(3):371–373. doi:10.1093/bja/82.3.37110434818
- Groban L. Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model. Reg Anesth Pain Med. 2003;28(1):3–11. doi:10.1053/rapm.2003.5001412567336
- Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Pract Res Clin Anaesthesiol. 2005;19(2):247–268.15966496
- Oussoren C, Zuidema J, Crommelin DJ, Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta. 1997;1328(2):261–272. doi:10.1016/s0005-2736(97)00122-39315622
- Halldin MM, Bredberg E, Angelin B, et al. Metabolism and excretion of ropivacaine in humans. Drug Metab Dispos. 1996;24(9):962–968.8886605
- Kopacz DJ, Emanuelsson BM, Thompson GE, Carpenter RL, Stephenson CA. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology. 1994;81(5):1139–1148. doi:10.1097/00000542-199411000-000077978472
- Yang S, Abrahams MS, Hurn PD, Grafe MR, Kirsch JR. Local anesthetic Schwann cell toxicity is time and concentration dependent. Reg Anesth Pain Med. 2011;36(5):444–451. doi:10.1097/AAP.0b013e318228c83521857272
- Kang DK, Zhao LY, Wang HL. [Cytotoxic effects of local anesthesia through lidocaine/ropivacaine on human melanoma cell lines]. Rev Bras Anestesiol. 2016;66(6):594–602. doi:10.1016/j.bjan.2016.08.00227639508
- Cai XY, Xiong LM, Yang SH, et al. Comparison of toxicity effects of ropivacaine, bupivacaine, and lidocaine on rabbit intervertebral disc cells in vitro. Spine J. 2014;14(3):483–490. doi:10.1016/j.spinee.2013.06.04123978626
- Fresenius Kabi, LLC, USA. NAROPIN (Ropivacaine hydrochloride); 1996 Available from: http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020533. Accessed 924, 1996.
- Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27–31. doi:10.4103/0976-0105.17770327057123